Treating refractory scleritis with infliximab.
Ahn
Seong Joon
SJ
Oh
Joo Youn
JY
Kim
Mee Kum
MK
Wee
Won Ryang
WR
D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D000069285:Infliximab; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D012163:Retinal Detachment / Q000000981:diagnostic imaging / Q000188:drug therapy; D012189:Retrospective Studies; D015423:Scleritis / Q000000981:diagnostic imaging / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology; D014463:Ultrasonography
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab